In Other News

• Nasal Spray for Protection Against COVID-19 Inhibits Infection of Host Cells by SARS‑CoV-2

• AI Platform Repositions Drugs That Can Combat Blood Clotting and Inflammation in COVID-19 Patients

• First-Ever Saliva-Based COVID and Influenza Combo Test to Screen for Coronavirus and Flu Infections

• Inflammation Cytokine Markers Could Predict COVID-19 Severity and Survival

• Cytokine Storms in COVID-19 Patients May Prevent Development of Long-Term Immunity to SARS-CoV-2 Virus

• Study Finds Link Between Molecule in Fat Tissue and Severe COVID-19

• Researchers Identify COVID Specific IgA Monoclonal Antibodies that Provide Immunity Against Novel Coronavirus

• New COVID-19 Pooling Test Method Identifies Asymptomatic Carriers

• Zymo Research’s Quick SARS-CoV-2 rRT-PCR Kit Receives CE-IVD Mark

• Beckman Coulter Launches New SARS-CoV-2 Immunoglobulin M (IgM) Antibody Test

• SARS-CoV-2 Acts as Sponge to Delete Specific Host microRNAs, Making it More Dangerous than Other Coronaviruses

• FDA Issues Emergency Use Authorization for Convalescent Plasma as Potential Promising COVID–19 Treatment

• Pfizer and BioNTech Release Positive Early Stage Data on mRNA COVID-19 Vaccine Trial

• Johnson & Johnson to Begin Largest, Late-Stage 60,000 Person COVID-19 Vaccine Trial in September

• New Transparent Facemask with Smart Capabilities Could Revolutionize COVID-19 Protection and Diagnostics

• Gilead’s Remdesivir Might Not Be as Effective For 'Moderate' Cases of COVID-19, Finds New Study

• Use of COVID-19 Tests without FDA Approval Could Bring New, Innovative Tests to Market More Quickly

• OpGen Launches Own-Developed CE-IVD Marked Molecular Diagnostic SARS-CoV-2 Kit with PULB in Europe

• AI-Driven Robotic Ultrasound System Uncovers Possible Breakthrough in Mechanically Ventilated COVID-19 Patients

• Tests to Detect Common Immune Signature in Blood of COVID-19 Patients Could Predict Severity of Disease

• Harvard Scientists Develop Broadly Deployable Biomaterials-Based Infection Vaccine Technology That Could Aid In COVID-19 Immunization

• LumiraDx SARS-CoV-2 Antigen Test Granted FDA Emergency Use Authorization

• Fitbit COVID-19 Study Finds Wearable Devices Can Identify Signs of Disease Before Symptoms Appear